Yoshihiro Noda1, Reza Zomorrodi2, Takashi Saeki3, Tarek K Rajji4, Daniel M Blumberger4, Zafiris J Daskalakis4, Motoaki Nakamura5. 1. Laboratory of Neuromodulation, Kanagawa Psychiatric Center, Yokohama, Japan; Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. 2. Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, Ontario, Canada. 3. Laboratory of Neuromodulation, Kanagawa Psychiatric Center, Yokohama, Japan. 4. Temerty Centre for Therapeutic Brain Intervention, Centre for Addiction and Mental Health, Toronto, Ontario, Canada; Department of Psychiatry, University of Toronto, Toronto, Ontario, Canada. 5. Laboratory of Neuromodulation, Kanagawa Psychiatric Center, Yokohama, Japan; ATR Brain Information Communication Research Laboratory Group, Kyoto, Japan. Electronic address: motoaki@motoaki.com.
Abstract
OBJECTIVE: We aimed to investigate neuromodulatory effects of high-frequency left dorsolateral prefrontal cortex repetitive transcranial magnetic stimulation (rTMS) on resting-state electroencephalography (EEG) and their clinical and cognitive correlates in patients with depression. METHODS: Thirty-one patients diagnosed with depression included in the present study. Resting-state gamma power and theta-gamma coupling (TGC) were calculated before and after a course of rTMS. We explored the relationship among gamma power, TGC, and clinical/cognitive outcomes as measured with the Hamilton Rating Scale for Depression (HAM-D17), Beck Depression Inventory (BDI), and Wisconsin Card Sorting Test (WCST). RESULTS: Following rTMS, depressed patients demonstrated significant increases of resting gamma power at the F3 and F4 electrode sites and resting TGC at the C3 and T3 electrode sites. Furthermore, the increased gamma power at the F3 electrode site was significantly correlated with improved score on the HAM-D17 and BDI, while the increased TGC at the C3 electrode site was significantly correlated with reduced number of errors on the WCST. CONCLUSION: Thus, resting-state gamma power and TGC may represent potential biomarkers of depression associated with therapeutic effects of rTMS. SIGNIFICANCE: Resting-state EEG may provide potential biomarkers related to therapeutic effects of rTMS. Copyright Â
OBJECTIVE: We aimed to investigate neuromodulatory effects of high-frequency left dorsolateral prefrontal cortex repetitive transcranial magnetic stimulation (rTMS) on resting-state electroencephalography (EEG) and their clinical and cognitive correlates in patients with depression. METHODS: Thirty-one patients diagnosed with depression included in the present study. Resting-state gamma power and theta-gamma coupling (TGC) were calculated before and after a course of rTMS. We explored the relationship among gamma power, TGC, and clinical/cognitive outcomes as measured with the Hamilton Rating Scale for Depression (HAM-D17), Beck Depression Inventory (BDI), and Wisconsin Card Sorting Test (WCST). RESULTS: Following rTMS, depressedpatients demonstrated significant increases of resting gamma power at the F3 and F4 electrode sites and resting TGC at the C3 and T3 electrode sites. Furthermore, the increased gamma power at the F3 electrode site was significantly correlated with improved score on the HAM-D17 and BDI, while the increased TGC at the C3 electrode site was significantly correlated with reduced number of errors on the WCST. CONCLUSION: Thus, resting-state gamma power and TGC may represent potential biomarkers of depression associated with therapeutic effects of rTMS. SIGNIFICANCE: Resting-state EEG may provide potential biomarkers related to therapeutic effects of rTMS. Copyright Â
Authors: Amin Zandvakili; Noah S Philip; Stephanie R Jones; Audrey R Tyrka; Benjamin D Greenberg; Linda L Carpenter Journal: J Affect Disord Date: 2019-03-30 Impact factor: 4.839
Authors: Heather Brooks; Mina Mirjalili; Wei Wang; Sanjeev Kumar; Michelle S Goodman; Reza Zomorrodi; Daniel M Blumberger; Christopher R Bowie; Zafiris J Daskalakis; Corinne E Fischer; Alastair J Flint; Nathan Herrmann; Krista L Lanctôt; Linda Mah; Benoit H Mulsant; Bruce G Pollock; Aristotle N Voineskos; Tarek K Rajji Journal: Cereb Cortex Date: 2022-04-05 Impact factor: 4.861
Authors: Alik S Widge; M Taha Bilge; Rebecca Montana; Weilynn Chang; Carolyn I Rodriguez; Thilo Deckersbach; Linda L Carpenter; Ned H Kalin; Charles B Nemeroff Journal: Am J Psychiatry Date: 2018-10-03 Impact factor: 18.112